Page last updated: 2024-11-06

triethylenemelamine and Medulloblastoma

triethylenemelamine has been researched along with Medulloblastoma in 2 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crue, BL1
Todd, EM1
Lockwood, RW1
Crist, WM1
Ragab, AH1
Vietti, TJ1
Ducos, R1
Chu, JY1

Other Studies

2 other studies available for triethylenemelamine and Medulloblastoma

ArticleYear
II. Medulloblastoma. Therapy with triethylene melamine and cobalt 60 irradiation.
    Bulletin of the Los Angeles neurological societies, 1967, Volume: 32, Issue:3

    Topics: Cerebellar Neoplasms; Cerebellum; Child; Cobalt Isotopes; Culture Techniques; Ependymoma; Glioma; Hu

1967
Chemotherapy of childhood medulloblastoma.
    American journal of diseases of children (1960), 1976, Volume: 130, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Child; Cyclophosphamide; Dexamethasone; D

1976